Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lisa Richards

Nurse Practitioner, Pediatrics Toledo, OH Nurse Practitioner

NPI 1669881249 CMS profile 10710566

2100 W Central Ave, Toledo, OH 43606

Open in the dashboard

General payments

$31,163

229 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lisa Richards of Toledo, OH is reported in the CMS Open Payments database as having received $31,163 across 229 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,112 48
2024 General $7,507 54
2023 General $11,377 59
2022 General $7,009 49
2021 General $2,157 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lisa Richards
  • Nurse Practitioner, Pediatrics median
  • Middle half of Nurse Practitioner, Pediatrics
  • National median

In program year 2025, general payments to Lisa Richards were reported at $3,112. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.

Show as a table
Year Lisa Richards Nurse Practitioner, Pediatrics median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $2,157 $60 $23–$142 $132
2022 $7,009 $72 $27–$161 $149
2023 $11,377 $89 $35–$185 $160
2024 $7,507 $93 $34–$199 $164
2025 $3,112 $93 $35–$201 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Dexcom, Inc. $24,081 70 payments
  2. Pfizer Inc. $2,754 23 payments
  3. Insulet Corporation $1,807 11 payments
  4. Novo Nordisk Inc $478 29 payments
  5. Tandem Diabetes Care, Inc. $391 23 payments
  6. AbbVie, Inc. $347 18 payments
  7. Sanofi-Aventis U.S. LLC $246 5 payments
  8. Tolmar, Inc. $195 10 payments
  9. Mannkind Corporation $109 5 payments
  10. Ascendis Pharma, Inc. $91 5 payments
  11. Other $665 30 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $14,955 14 payments
  2. Travel and Lodging $9,634 25 payments
  3. Food and Beverage $4,699 187 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $975 2 payments
  5. Consulting Fee $900 1 payment
Products named General payments · program years 2021–2025
  1. DEXCOM G7 GSS (161) $15,415 28 payments
  2. Dexcom G6 Transmitter Endocrinology $6,771 38 payments
  3. GENOTROPIN $2,754 23 payments
  4. DEXCOM G6 TRANSMITTER Endocrinology $1,895 4 payments
  5. Omnipod $1,807 11 payments
  6. DEXCOM STELO GLUCOSE BIOSENSOR $600 1 payment
  7. t:slim X2 Insulin Pump with Control-IQ $374 22 payments
  8. LUPRON DEPOT $347 18 payments
  9. TZIELD $246 5 payments
  10. NGENLA $188 14 payments
  11. Other $1,880 97 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

229 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record